Blackstone Inc. (BX) — Quantitative Forecast & Factor Scores
BX screens as quality-oriented and fully priced — DCF model implies a +21% margin of safety at current levels.
BX's quantitative grade is Hold, with elevated downside risk (CVaR -24.2%), and quality metrics (net margin 21%, ROE 29%). Blackstone Inc. (BX) trades at $114.87 with a valuation grade of Hold: a trailing P/E of 29.6x at a 111% premium to sector median, net margins of 21.2%, a DCF-implied intrinsic range of $102–$177 suggesting a +21% margin of safety, beta 1.79 (highly aggressive risk profile).
Key Takeaways
- Valuation: Hold grade — P/E 29.6x — DCF range $102–$177 implies +21% margin of safety
- Risk: CVaR -24.2% (95th percentile, 1-month) indicates moderate tail exposure; beta of 1.79 amplifies broad market moves in both directions
- Strengths: Quality 4.0/5, Size 4.0/5, 21% net margin, 29% ROE dominate the factor profile
- Watch: Value score of 2.0/5 signals premium pricing
Quantitative Factor Profile
Key Metrics
| Metric | Value |
|---|---|
| Current Price | $114.87 |
| P/E Ratio (TTM) | 29.6x |
| Forward P/E | 14.7x |
| P/S Ratio | 9.9 |
| Beta | 1.79 |
| Net Margin | 21.2% |
| ROE | 29.2% |
| Debt/Equity | 66.5% |
| Dividend Yield | 4.12% |
| CVaR (95%, 1M) | -24.2% |
| Market Cap | $140.4B |
Earnings History
| Quarter | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| Q4 2025 | $1.54 | $1.75 | +13.9% ✓ |
| Q3 2025 | $1.23 | $1.52 | +23.9% ✓ |
| Q2 2025 | $1.10 | $1.21 | +9.8% ✓ |
| Q1 2025 | $1.06 | $1.09 | +3.1% ✓ |
BX vs. Sector Peers
| Ticker | P/E (TTM) | Beta | CVaR-95 | Net Margin |
|---|---|---|---|---|
| BX | 29.6x | 1.79 | -24.2% | 21.2% |
| KKR | 39.1x | 2.01 | -26.0% | 9.2% |
| APO | 20.1x | 1.64 | -21.5% | 11.0% |
| ARES | 62.6x | 1.56 | -30.5% | 9.4% |
| CG | 22.3x | 2.06 | -20.4% | 20.1% |
BX screens as a high-quality business, at a fully-priced valuation with limited margin of safety. The four-quarter earnings beat streak is constructive, with improving surprise magnitude (+13.9% most recently).
BX trades at 29.6x trailing earnings — 111% above the Financials sector median of 14.0x. The DCF model implies a +21% margin of safety — the risk/reward is currently skewed to the upside.
BX is not a name I am actively adding to. The business quality is real, but at 30x I am already paying for a lot of the future, and the margin of safety does not justify conviction-sized exposure. What I watch on this name is earnings consistency — specifically whether delivery against consensus is stable or deteriorating. That is usually where the rating gets confirmed or challenged before the price reflects it. A pullback of 10–15% from here would open the margin of safety enough that I would want to add. An earnings miss at the current multiple would do the opposite — that would be the signal to reduce rather than wait.
Is BX a buy, hold, or sell?
BX carries a valuation grade of Hold. The trailing P/E of 29.6 sits 111% above the Financials sector median of 14.0x — a premium that demands sustained earnings delivery. Our discounted cash flow model produces an intrinsic range of $102–$177 — implying a +21% margin of safety at the current price of $114.87. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate.
BX has beaten consensus estimates in 100% of recent quarters, signalling strong execution consistency. The most recent quarter delivered a 13.9% earnings surprise. Analyst estimate revisions are trending upward.
What are BX's key risk factors?
With a beta of 1.79, BX exhibits a highly aggressive risk profile relative to the broad market. The 95th-percentile CVaR of -24.2% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 2.4% of total portfolio loss in the worst 5% of months. Net margins of 21.2% fall below the Financials sector average of 28%, suggesting margin pressure. Return on equity of 29.2% indicates highly efficient capital allocation. The balance sheet is conservatively leveraged at 67% debt-to-equity.
The options market shows a put/call ratio of 1.37, reflecting a notably bearish skew in derivative positioning. Implied volatility of 48.9% exceeds realized volatility of 41.2% by 8 points, suggesting options are pricing in elevated risk. Insiders have been net sellers to the tune of $95.7M recently. While routine dispositions are common, the magnitude bears watching. Short interest is low at 2.0% of float, suggesting limited bearish conviction.
How does BX fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — BX carries a beta of 1.79, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
As a Financials constituent, BX's risk profile should be evaluated alongside sector peers when constructing diversified portfolios.
True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The BX analysis here is a single node in that larger structure.
Run BX in Asset Lens
Live DCF valuation, Monte Carlo simulation, options flow intelligence, and full factor decomposition — updated in real time. Free, no account required.
Launch Live Analysis →This analysis is produced using a systematic quantitative framework applied to market data and does not constitute investment advice. Prose commentary is AI-assisted and generated from structured quantitative inputs. All data and metrics are as of 2026-04-01 and are point-in-time estimates subject to revision without notice. CVaR figures are based on historical simulation and do not guarantee future outcomes. DCF ranges and upgrade/downgrade triggers are forward-looking statements based on current assumptions and may not materialise. Past performance does not guarantee future results. This analysis does not account for individual circumstances, tax position, or investment objectives — consult a qualified financial advisor before making investment decisions. This content is intended for informational purposes only and does not constitute regulated investment advice under MiFID II or FCA guidelines. This content is not intended for US persons or residents of jurisdictions where its distribution would be contrary to local law or regulation. This service is not directed at residents of Finland, Sweden, Norway, Denmark, Iceland, or Poland. The author may hold long or short positions in securities mentioned in this analysis. Nothing on this page represents a solicitation to buy or sell any security. A.L. Capital Advisory is an independent private advisory practice and is not affiliated with Blackstone Inc.